In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Genaissance enters into technology license agreement with Millennium
Iconix and Millennium Pharmaceuticals form agreement
Millennium discovers novel cardiovascular drug target
StemCells grants license to BioWhittaker
ImmunoGen and Millennium sign exclusive product license
Millennium delivers antibacterial target for screening to Wyeth-Ayerst
Millennium and MorphoSys extend collaboration
Physiome licenses biological modeling technology to 3rd Millennium